← The Wire
TOVXNYSE
Theriva Biologics, Inc.
Pharmaceutical Preparations · NV · CIK 894158
Developing oncolytic adenovirus therapeutics to treat cancer and related diseases
$14M
Market cap
$0.26
Last close
+4.1%
1D
+2.8%
5D
1.2M
Volume
Price · last 39 sessions-31.5%
May 4L $0.24 · H $0.38Jun 29
572
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
10-K10-KMar 12, 202610-K10-KMar 6, 202510-K10-KMar 25, 202410-K10-KMar 30, 202310-K10-KMar 16, 202210-KFORM 10-KMar 4, 202110-KFORM 10-KFeb 20, 202010-KFORM 10-KFeb 27, 201910-KFORM 10-KFeb 22, 201810-KFORM 10-KMar 2, 201710-K10-KMar 10, 201610-K10-KMar 16, 201510-KFORM 10-KMar 31, 201410-K10-KApr 16, 201310-KFORM 10-KMar 30, 201210-K10-KMar 31, 201110-KFORM 10-KMar 31, 201010-KADEONA PHARMACEUTICALS FORM 10-KMar 31, 200910-KFORM 10-KMar 31, 200810-KFORM 10-KApr 15, 200310-KFORM 10-KMar 29, 200010-KFORM 10-KMar 24, 199910-KFORM 10-KApr 15, 1998
Similar companies
Comparable business profile · signals at a glance